Human Tumor Growth Suppression by Apoptosis Induced with Anti-ErbB-2 Chimeric Monoclonal Antibody

This publication has 26 references indexed in Scilit:

• A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging
  Japanese Journal of Cancer Research, 1996
• Significance of erb B‐2 Gene Product as a Target Molecule for Cancer Therapy
  Scandinavian Journal of Immunology, 1994
• Establishment and Characterization of Mouse‐Human Chimeric Monoclonal Antibody to erbB‐2 Product
  Japanese Journal of Cancer Research, 1994
• Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbb-2 (her-2/neu) gene product p185
  International Journal of Cancer, 1993
• Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
  Journal of Clinical Immunology, 1991
• Selection of monoclonal antibodies which induce internalization and phosphorylation of P185^HER2 and growth inhibition of cells with HER2/neu gene amplification
  International Journal of Cancer, 1991
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.
  The Journal of Experimental Medicine, 1989
• Amplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma
  Science, 1985
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985